Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executi... ( FORT LAUDERDALE Fla. July 10 /- S...)

Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executive Officer

Date:7/10/2008

FORT LAUDERDALE, Fla., July 10 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that Mr. Jyotindra Gange, has been appointed Principal Executive Officer of the Company and in such capacity given the responsibility of overseeing all executive functions. Mr. Gange is currently a member of Synovics' board of directors and is the Chief Financial Officer of Maneesh Pharmaceuticals, LTD., a leading privately held pharmaceutical company based in India and a joint venture partner with Synovics. Maneesh Pharmaceuticals LTD. is a significant investor in Synovics Pharmaceuticals, Inc. Previously, Mr. Gange served as Chief Financial Officer of Multi Arc India Ltd., a provider of industrial coatings and Bharat Serums and Vaccines Ltd., an Indian pharmaceuticals company. Mr. Gange was also Vice President - Finance at Universal Ferrous Ltd., a producer of ferro alloys. Mr. Gange is a Chartered Accountant in India. Ronald Howard Lane, Ph.D., resigned as the Company's Chief Executive Officer and will remain as its Chairman of the Board.

"We are very pleased to announce the appointment of Mr. Gange as Principal Executive Officer," stated Dr. Lane. "This step is part of an ongoing series of planned undertakings by our board that are intended to position the Company for growth and give it the capacity to access the advantages represented by our 'Front-End' strategy with India pharmaceutical companies. Mr. Gange brings a wealth of experience to Synovics, both financial and operational, and the board expects that he will make a significant impact on our development and business."

"I am excited about the potential Synovics Pharmaceuticals represents, in both prescription and over-the counter (OTC) drug markets," commented Mr. Gange. "Our current product mix and pharmaceutical licenses provides a wonderful foundation for this Company. The management team in the operating businesses
'/>"/>

SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
2. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
3. Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:

(Date:12/2/2009)... Links Medical Products I... hospitals and nursing homes, announces the openin...The new facility is located at 9247 Research Drive...ical maintains another facility in the Irvine Spec...n Indio, California. This most recent expansion re...

(Date:12/2/2009)... Tampa law firm prevails ...iled lawsuit against ConArt as part of business di...s , Tampa, Fla. (Lexis Ne...of Gallagher Keenan, P.A. recently completed the...ted in a $500,000 award for the firm,s client, Con...

(Date:12/2/2009)..., , CAMPBELL, Calif., Dec. 1 /PRNews...icated radio show, Dr. Rafael Pelayo, Associate Pr...Stanford University School of Medicine, recommende... a healthy sleep plan for people trying to achieve... ,, "Background noise is a problem for people w...

(Date:12/2/2009)..., , CHICAGO, Dec. 2 /PRNewswire-USNewswire...s of the breast, including lumps, is a safe, relia...psies for women under age 40, according to the fin... meeting of the Radiological Society of North Amer...st ultrasound, we can reduce the number of expensi...

(Date:12/2/2009)... CHICAGO A randomized, controlled study comparin...asive treatment called percutaneous disc decompres...e both treatments help patients in the short run, ... to two years later. Results of the study, the fir... meeting of the Radiological Society of North Amer...

Breaking Medicine News(10 mins):Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2 Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3 Health News:Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies 2 Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2 Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3 Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2 Health News:Outpatient disc treatment gives long-term back pain relief 2

[0] Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey [0] Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies [0] Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine [0] Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty [0] Outpatient disc treatment gives long-term back pain relief

... researchers have identified a genetic marker that...ancer in Caucasian men who have a family history o...marker may help clinicians personalize prostate ca...ata at the annual meeting of the American Society ...

...NYSE: SNN ; LSE: SN) Orthopaedics business annou...he Orthopaedic Research and Education Foundation (...s. Smith & Nephew announced in January it ente...financial support of research and education in ort...

...e five years of age, could save society up to $65 ...an examination of childhood health conducted by re... Public Health. The results are published in the M...sure, unintentional injury, obesity and mental hea...

...nt by Jeff Levi, Ph.D., Executive Director of Trus...f Thomas R. Frieden to serve as Director of the U....): , , "Dr. Frieden is a bold leader who has the ...ve strategies have led to real reductions in smoki...

... Affairs (VA), the nation,s largest single employe..., by honoring six of its top professionals. , , "...ch and every day, put the quality, compassion and ...America." VA health care facilities throughout th...

...uced A1C and LDL-C in Patients with Type 2 Diabete...he Safety and Durability of Welchol for up to 78 W...aiichi Sankyo, Inc. (DSI) announced today that dat...d mean LDL cholesterol (LDL-C) when added to metfo...

Genetic marker may predict early onset of prostate cancer Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund Early childhood health interventions could save billions in health costs later in life Trust for America's Health Supports Appointment of Thomas Frieden to Lead CDC VA Honors Top Nurses Delivering Veterans' Care Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes

(Date:12/1/2009)... BELLEVUE, Wash., Dec. 1 ...nline retailer of health, beauty, vision, and phar...as its best day ever as customer orders were the h... drugstore.com and Beauty.com web stores featu... their largest gift selection yet. ,, (Logo: h...

(Date:12/1/2009)... NEW YORK, Dec. 1 Reportlinker.com...ailable in its catalogue: ,, Direct to Consume...nd Future Market Outlook, Regulatory Landscape and...p0166813/Direct-to-Consumer-DTC-Advertising-in-Pha...egulatory-Landscape-and-Case-Studies.html ,, ...

(Date:12/1/2009)...gist reports 90 percent radiation reduction in car...Newswire/ -- Dr. James Earls, a radiologist from F...gton, D.C. will present the findings of a study th...adiation heart patients received from CT scans com.... Earls will present the study to the annual meeti...

Breaking Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2 drugstore.com, inc. Has Best Day Ever on Cyber Monday 3 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8 Radiation Reduction in Heart CT Scans Reported in Study 2 Distinctive Voices@The Beckman Center announces fall lecture series 9832 1 Plants on steroids 3A Key missing link discovered 9829 1 Plants on steroids 3A Key missing link discovered 9829 2 Safe Blood for Africa Foundation and Hema Quebec Sign Far Reaching Agreement 56461 1 Safe Blood for Africa Foundation and Hema Quebec Sign Far Reaching Agreement 56461 2

[0] drugstore.com, inc. Has Best Day Ever on Cyber Monday [0] Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies [0] Radiation Reduction in Heart CT Scans Reported in Study

...POLIS, France, May 13 NicOx S.A.,(Eurolist: COX) ...ed the,first in a series of planned clinical studi...er the companies, collaborative agreement to,devel...ts using NicOx,proprietary technology. Three drug ...es, joint research program, of which two have comp...

...udy opens way for high-power permanent version of ...w study, BOSTON, May 12 Innovative prism glasses...y lives of patients with,hemianopia, a condition t...,peripheral prism glasses, which were invented by ...esearch Institute, were evaluated in the first,com...

Other Medicine Technology:NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2 NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3 Prism Glasses Expand the View for Patients with Hemianopia 2 Prism Glasses Expand the View for Patients with Hemianopia 3

NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.Prism Glasses Expand the View for Patients with Hemianopia

... magnification for advanced surgical procedures. P...ven at the highest magnification. 3.5x, 4.5x and 5...ion is ideal for surgical applications. Precision ...duce a superior image. The compact abd lightweight...

... high power negative lens delivering magnification...system is ease of use. Movement whilst maintaining...depth of field. The ultra lightweight aluminum bar... stability for the mounted loupes and optimal foca...

SuperVu Galilean System

Anterior Chamber Irrigating Cannula

Medicine Products:

XL Advantage 3.5x @ 34cm working distance SuperVu 2.0x Galilean system SuperVu Galilean System Anterior Chamber Irrigating Cannula

Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executi...( FORT LAUDERDALE Fla. July 10 /- S...),Health